# FLUTICASONE PROPIONATE
> **ANDA218321** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2025-06-05
## Drug
- **FDA Application Number:** ANDA218321
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUTICASONE PROPIONATE
- **Generic name:** FLUTICASONE PROPIONATE
- **Active ingredients:** FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2025-06-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218321)
---
*MORVS · CC0 1.0*